Completion of acq. of Inv. Adviser by Octopus Cap.

RNS Number : 1538T

The MedicX Fund Limited

01 October 2014

 



1 October 2014

MedicX Fund Limited

("MedicX Fund", the "Fund" or the "Company")

Completion of acquisition of Investment Adviser by Octopus Capital

MedicX Fund (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, confirms that further to the announcement on 4 July 2014, Octopus Investments Limited ("Octopus") via its parent company, Octopus Capital Limited ("Octopus Capital"), has today completed its acquisition of MedicX Group including MedicX Adviser Ltd, the Investment Adviser to MedicX Fund.

Octopus is a fast-growing UK fund management company with leading positions in several specialist sectors, and is expanding its healthcare business through the acquisition of MedicX Group, a market-leading UK healthcare real estate investment manager.  As a result of the acquisition, Octopus' funds under management have increased to over £4.7 billion.

Mike Adams, CEO of MedicX Group, will continue to lead the existing team following the acquisition and MedicX Fund will remain a core focus for MedicX Adviser Ltd.

David Staples, Chairman of MedicX Fund, said:

"We look forward to MedicX Fund being able to build on its success to date under Mike's leadership of the investment adviser and to draw on the support and expertise of the wider Octopus group. Octopus has made it clear that it intends to be a long term owner, and it recognises the excellent working relationship and clear focused strategy that has been shared by the Board of MedicX Fund and MedicX Adviser Ltd to enable the Fund to build a market leading portfolio, high quality debt facilities, a strong performance track record and a loyal and diverse shareholder register."

End

For further information please contact:

MedicX Fund                                                                  [phone]

David Staples, Chairman

MedicX Group                                                                [phone]

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Canaccord Genuity Limited                                              [phone]

Andrew Zychowski / Helen Goldsmith

Buchanan Communications                                              [phone]

Charles Ryland / Sophie McNulty

Information on MedicX Fund Limited

MedicX Fund Limited is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 136 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK.  

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

Information on Octopus Investments

Octopus Investments is a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare, energy and smaller company investing. 

Founded in 2000, Octopus manages more than £3.5 billion of funds on behalf of 50,000 investors.  As a result of the acquisition, Octopus' funds under management have increased to over £4.7 billion.

Octopus' core product range includes Venture Capital Trusts, Enterprise Investment Schemes and Inheritance Tax Services offering award-winning solutions for investors looking for capital growth, income generation or capital preservation. 

For further information, visit www.octopusinvestments.com.

 

END

 

 

MSCEAEEFESSLFFF